Kleyton Santos de Medeiros

Prof. Dr. Kleyton Santos de Medeiros

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
IXIvete Matias Xavier
Ivete Matias Xavier
ASAna Carolina Zimmermann Simões
Ana Carolina Zimmermann Simões
RORonnier de Oliveira
Ronnier de Oliveira
YBYasha Emerenciano Barros
Yasha Emerenciano Barros
ASAyane Cristine Alves Sarmento
Ayane Cristine Alves Sarmento
AGAna Katherine Da Silveira Gonçalves
Ana Katherine Da Silveira Gonçalves
The objective of this study was to determine adverse maternal and perinatal outcomes in pregnant women with hypertensive disorders of pregnancy.

3 June 2024 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
LPLisieux de Lourdes Martins Nóbrega Pessoa
Lisieux de Lourdes Martins Nóbrega Pessoa
Amaxsell Thiago Barros de SouzaAmaxsell Thiago Barros de Souza
Amaxsell Thiago Barros de Souza
ASAyane Cristine Alves Sarmento
Ayane Cristine Alves Sarmento
ACAna Paula Ferreira Costa
Ana Paula Ferreira Costa
ISIsis Kelly Santos
Isis Kelly Santos
Ricardo CobucciRicardo Cobucci
Ricardo Cobucci
Objective: This meta-analysis of randomized controlled trials (RCTs) aimed to update evidence on the effectiveness and safety of laser therapy for treating genitourinary syndrome of menopause (GSM). Data sources: Manuscripts published until May 2023 were systematically searched in PubMed; Embase; Scopus; Web of Science; CENTRAL; CINAHL; and clinical trial databases (www.trialscentral.org, www.controlled-trials.com, and clinicaltrials.gov), […] Abstract Objective: This meta-analysis of randomized controlled trials (RCTs) aimed to update evidence on the effectiveness and safety of laser therapy for treating genitourinary syndrome of menopause (GSM). Data sources: Manuscripts published until May 2023 were systematically searched in PubMed; Embase; Scopus; Web of Science; CENTRAL; CINAHL; and clinical trial databases (www.trialscentral.org, www.controlled-trials.com, and clinicaltrials.gov), […]

28 June 2024 in Heliyon
Verified
Journal Article
Open access
KSKauanny Vitoria Gurgel dos Santos
Kauanny Vitoria Gurgel dos Santos
JDJoyce Karolayne dos Santos Dantas
Joyce Karolayne dos Santos Dantas
TFThatiane Evelyn de Lima Fernandes
Thatiane Evelyn de Lima Fernandes
KMKleyton Santos de Medeiros
Kleyton Santos de Medeiros
ASAyane Cristine Alves Sarmento
Ayane Cristine Alves Sarmento
Rodrigo Assis Neves DantasRodrigo Assis Neves Dantas
Rodrigo Assis Neves Dantas
Objectiveto evaluate the effectiveness of using music to relieve pain, anxiety, and change in vital signs in adult and older adult patients undergoing cardiac catheterization. Methodsthis is a systematic review with meta-analysis carried out in October 2022, using 12 data sources, without time or language restrictions. The study followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The “Risk-of-bias tool” was used to assess the risk of bias, the “R CORE Team program: A language and environment for statistical computing” was used to perform the meta-analysis, and the “Grading of Recommendations Assessment, Development and Evaluation” was used to assess the quality of evidence in the studies. a total of nine studies were included, totaling 1456 participants. The most used tools for measuring anxiety were the State-Trait Anxiety Inventory and Numerical Rating Scale. This was also used to measure pain, in addition to the Visual Analogue Scale. The use of instrumental, classical and relaxing music prevailed, applied using headphones during the painful procedure, at a frequency of 60 to 100bpm and sound intensity of 60–70 dB. There was statistical significance in the use of music in reducing pain, anxiety and systolic blood pressure. music interventions are effective in relieving pain, reducing systolic pressure and anxiety, but indifferent in terms of heart rate, respiratory rate and diastolic pressure. They provide humanization of care, can reduce hospital costs and length of hospital stay.

17 June 2022 in Medicine
Verified
Journal Article
Open access
RSRomeika Lorena Mendes Bsc da Silva
Romeika Lorena Mendes Bsc da Silva
TSTâmara Taynah Medeiros da Silva
Tâmara Taynah Medeiros da Silva
RPRenata Lima Pessoa
Renata Lima Pessoa
ASAyane Cristine Alves Sarmento
Ayane Cristine Alves Sarmento
KMKleyton Santos de Medeiros
Kleyton Santos de Medeiros
Rodrigo Assis Neves DantasRodrigo Assis Neves Dantas
Rodrigo Assis Neves Dantas
Introduction: Uterine cervix tumors have an invasive nature, with the capacity to proliferate to surrounding organs such as the vagina, bladder, and rectum, as well as the capacity for dissemination and involvement of structures distant from its place of origin. According to the International Federation of Gynecology and Obstetrics, patients with stages IB I, IB I microscopic (small dimension <4 cm) are indicated for radiotherapy or adjuvant chemoradiotherapy with cisplatin (40 mg/m2). However, cisplatin has side effects such as hematological implications (anemia, neutropenia, and thrombocytopenia), gastrointestinal disorders (nausea, vomiting, diarrhea, constipation), and fatigue. Zingiber officinale contains bioactive compounds that act on pregnancy and postoperative nausea, chemotherapy-induced nausea and vomiting, and also in the management of fatigue, myalgia, and insomnia. This study aimed to evaluate the effects of ginger on chemotherapy-induced nausea and vomiting in patients with cervical cancer undergoing treatment with cisplatin and radiotherapy. Methods and analyses: A randomized intervention clinical and controlled trial with a triple-blind design is described, comparing the effects of institutional antiemetic therapy alone, as well as in combination with 2 different ginger concentrations. Ethics and dissemination: Due to the nature of the study, we obtained approval from the Division Ethics Committee of Liga Contra o Câncer. All participants signed an informed consent form prior to randomization. The results of this study will be published in peer-reviewed journals. The data collected will also be available in a public repository of data. Trial registration number: This study is registered in the Brazilian Registry of Clinical Trials under number RBR-47yx6p9. This study was approved by the Division Ethics Committee of Liga Contra o Câncer under CAAE 40602320.0.0000.5293.

1 January 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
KMKleyton Santos de Medeiros
Kleyton Santos de Medeiros
LSLuís Antônio Soares da Silva
Luís Antônio Soares da Silva
LMLuíza Thomé de Araújo Macêdo
Luíza Thomé de Araújo Macêdo
ASAyane Cristine Alves Sarmento
Ayane Cristine Alves Sarmento
ACAna Paula Ferreira Costa
Ana Paula Ferreira Costa
AGAna Katherine Da Silveira Gonçalves
Ana Katherine Da Silveira Gonçalves
BACKGROUND: Although much has been studied about the SARS-Cov-2 virus, its effects, and the effectiveness of possible treatments, little is known about its interaction with other infectious diseases. OBJECTIVE: The aim is to study its clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection. DATA SOURCES: MEDLINE, Web of Science, Embase, CINAHL, LILACS, Scopus, ClinicalTrials.gov, and Cochrane. STUDY ELIGIBILITY CRITERIA: Atudies in any language, published after 2019, were describing COVID-19 patients with HIV/AIDS. STUDY APPRAISAL: JBI Levels of Evidence, Joanna Briggs Institute. SYNTHESIS METHODS: As shown in the PRISMA flow diagram, two authors separately screened the search results from the obtained titles and abstracts. RESULTS: Chest CT was observed in patients with pneumonia by SARS-CoV-2 with findings of multiple ground-glass opacities (GGO) in the lungs, there is a need for supplemental oxygenation. One patient developed encephalopathy and complicated tonic-clonic seizures; four patients were transplanted (two, liver; two, kidneys), one patient developed severe SARS-CoV-2 pneumonia and 30 patients died (mortality rate, 11%). CONCLUSION: HIV did not show any relevance directly with the occurrence of COVID-19. Some studies suggest that HIV-1 infection through induction levels of IFN-I, may to some extent, stop the apparent SARS-CoV-2 infection, thus leading to undetectable RNA. Moreover, some authors suggest retroviral therapy routinely used to control HIV infection could be used to prevent COVID-19 infection.

5 July 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
ASAyane Cristine Alves Sarmento
Ayane Cristine Alves Sarmento
FFFabíola S Fernandes
Fabíola S Fernandes
ACAna Paula Ferreira Costa
Ana Paula Ferreira Costa
KMKleyton Santos de Medeiros
Kleyton Santos de Medeiros
JCJanaina Cristina Crispim
Janaina Cristina Crispim
AGAna Katherine Da Silveira Gonçalves
Ana Katherine Da Silveira Gonçalves
Introduction Menopause is a physiological and progressive phenomenon secondary to decreased ovarian follicular reserve. These changes have consequences: vaginal dryness, dyspareunia, discomfort, burning and irritation, vulvovaginal pruritus, dysuria and increased frequency of genitourinary infections. The therapy more suitable for vaginal symptoms in postmenopause yet is the use of a topical hormone. However, the prescription of topical oestrogens should also be avoided in women with a history of breast cancer, oestrogen-sensitive tumours and thromboembolism, emphasising the necessity of alternative treatments. Recently, physical methods, such as laser and radiofrequency (RF), in their non-ablative, ablative and microablative forms have been used in the vaginal mucosa to promote neocolagenesis and neoelastogenesis. This randomised study aims to compare the efficiency of microablative fractional RF (MAFRF) treatment with vaginal oestrogens and no treatment. Methods and analyses This randomised, controlled clinical intervention trial with an open label design comparing the treatment of MAFRF with vaginal oestrogens and no treatment. Four important moments were considered to evaluate treatment results (T0, T1, T2 and T3). The primary outcome includes vulvovaginal atrophy (vaginal pain, burning, itching, dryness, dyspareunia and dysuria), and the secondary outcomes will be sexual function, vaginal health (epithelial integrity, vaginal elasticity, moisture, fluid volume and vaginal pH) and quality of life. Ethics and dissemination Due to the nature of the study, we obtained approval from the ethics committee. All participants must sign an informed consent form before randomisation. The results of this study will be published in peer-reviewed journals. The data collected will also be available in a public repository of data. Trial registration number RBR-94DX93.